Glucotrack, Inc (GCTK) insider trading
Every open-market stock purchase and sale by Glucotrack, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: John Ballantyne (10% owner), $4M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent GCTK insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 3, 2025 | Luis Malave (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Andrew K Balo (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Andrew K Balo (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Erin Catherine Carter (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Erin Catherine Carter (Director) | Bought (not open market) | — |
| Oct 3, 2025 | Luis Malave (Director) | Bought (not open market) | — |
Who's trading GCTK
- Andrew K Balo, Director: other filings, last Oct 3, 2025
- Erin Catherine Carter, Director: other filings, last Oct 3, 2025
- Luis Malave, Director: other filings, last Oct 3, 2025
Get free alerts when an insider at Glucotrack, Inc files a new trade →